Marquette Asset Management’s Utah Medical Products UTMD Stock Holding History

Marquette Asset Management’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-263	Closed	-$24K	–	429
2022 Q1	$24K	Hold	263	–	–	0.01%	231
2021 Q4	$26K	Hold	263	–	–	0.01%	218
2021 Q3	$24K	Hold	263	–	–	0.01%	216
2021 Q2	$22K	Hold	263	–	–	﹤0.01%	205
2021 Q1	$23K	Hold	263	–	–	0.01%	194
2020 Q4	$22K	Hold	263	–	–	0.01%	197
2020 Q3	$21K	Hold	263	–	–	0.01%	182
2020 Q2	$23K	Hold	263	–	–	0.01%	192
2020 Q1	$25K	Hold	263	–	–	0.01%	185
2019 Q4	$28K	Hold	263	–	–	0.01%	163
2019 Q3	$25K	Hold	263	–	–	0.01%	189
2019 Q2	$25K	Hold	263	–	–	0.01%	182
2019 Q1	$23K	Buy	+263	New	+$23.1K	0.01%	190

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Marquette Asset Management's UTMD Position: Q2 2022 in Review

Marquette Asset Management sold out of Utah Medical Products (UTMD) in Q2 2022, closing a stake of 263 shares — an estimated $24K sold.

Marquette Asset Management first reported a position in UTMD in Q1 2019 and held it in 13 quarters. The position peaked at $28K in Q4 2019. 75 funds tracked by Wall St. Rank hold UTMD as of Q2 2022.

Marquette Asset Management reported no remaining Utah Medical Products position as of Q2 2022 after selling out during the quarter.
Marquette Asset Management sold 263 Utah Medical Products shares in Q2 2022, an estimated $24K.
Marquette Asset Management first reported a position in Utah Medical Products in Q1 2019 and held it in 13 quarters.
Marquette Asset Management's Utah Medical Products position peaked at $28K in Q4 2019.
75 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2022.

Based on Marquette Asset Management's 13F filing for Q2 2022, filed 15 Jul 2022.